Drug application
IMIPRAMINE HYDROCHLORIDE (IMIPRAMINE HYDROCHLORIDE)
Drugs@FDA ANDA 086765 · NOVARTIS
Key facts
| Drug name | IMIPRAMINE HYDROCHLORIDE |
|---|---|
| Active ingredients | IMIPRAMINE HYDROCHLORIDE |
| Application type | ANDA |
| Application number | 086765 |
| Company | NOVARTIS |
| Dosage forms | CONCENTRATE, ORAL |
| Strength | 25MG/ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
At a glance
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.